11. RFLP (A/O Alleles vs. B Allele)

 

Similarly, the sequences around the first and second of the four amino acid substitutions that discriminate A/O and B alleles can be cleaved by BssHII and NarI, and HpaII and AluI, respectively. Using restriction fragment length polymorphism (RFLP), we confirmed the presence of these differences in genomic DNAs from the cell lines used to prepare cDNA libraries (these distinctions in RNAs were previously determined by the nucleotide sequencing of cloned cDNAs). As opposed to KpnI and BstEII, which recognize and cleave longer nucleotide sequences, HpaII and AluI are frequent cutters, recognizing and cleaving shorter sequences. As such, we used PCR to amplify DNA fragments containing those restriction sites and then digested with these enzymes, rather than Southern hybridization. We used the same strategy for the BssHII and NarI distinction, though they are not frequent cutters because of easier experimental protocols. When we performed these experiments, the specificity of the Taq DNA polymerase was not as good as it is now. Therefore, several additional bands are visible in the background. Nonetheless, the presence/absence of the restriction sites could be determined easily.

12. ABO Genotyping of Blood Specimens

01. ABO Blood Group System

Yamamoto, F., Clausen, H., White, T., Marken, J., and Hakomori, S. (1990). Molecular genetic basis of the histo-blood group ABO system. Nature 345, 229-233. (http://www.nature.com/nature/journal/v345/n6272/abs/) 


Keywords

Histo-blood group ABO system, blood group ABO system, ABO system, AB0 system, ABO blood groups, AB0 blood groups, ABO blood types, AB0 blood types, ABO genetic locus, ABO genes, ABO, AB0, A glycosyltransferases, B glycosyltransferases, glycosyltransferases, A transferase, B transferase, cell surface antigens, carbohydrate antigens, oligosaccharide antigens, oligosaccharides, complex carbohydrate antigens, complex carbohydrates, A antigen, B antigen, H antigen, red blood cell antigens, A/B antigens, ABH antigens, glycolipid, glycosphingolipids, glycoproteins, oligo sugars, red blood cells, RBC, blood transfusion, transfusion medicine, cell/tissue/organ transplantation, transplantation medicine, immunohematology, immunohaematology, immuno-hematology, immunology, ABO genotyping, forensic sciences, legal medicine, human genetics, population genetics, evolution, enzymology, glycobiology, glycosciences, human genes, primate genes, mouse gene, pig genes, alpha 1,3-Gal(NAc) transferases, a1,3-galactosyl transferase, a1,3-GalNAc transferase, structural basis, molecular genetic basis of ABO, ABO polymorphism, single nucleotide polymorphism, SNP, A, B, AB, O, A2, A3, Ax, B3, alleles, weak subgroups, homo sapiens, pig AO genes, cis-AB, B(A), mouse cis-AB gene, ABO genotype, ABO phenotype, DNA methylation, transcription, alternative splicing, Golgi apparatus, transferase chimeras, GBGT1, GGTA1, A3GALT2, monoclonal antibody, sera, plant lectins, Fumi-ichiro Yamamoto, Fumiichiro Yamamoto, F. Yamamoto, Landsteiner, enzyme, kinetics, sugar specificity, acceptor substrate specificity, acceptors, donors, sugars, nucleotide-sugars, genetic engineering, differential susceptibility to infectious diseases, differential cancer susceptibility, alterations in glycosylation in cancer, pancreatic cancer, diets, Peter D'Adamo, Blood type diets, neurobiology, Masahiko Nomi, personality, Burnham Institute, Burnham Institute for Medical Research, Biomembrane Institute, IMPPC, IMPPC Institute of Predictive and Personalized Medicine of Cancer, Institut de Medicina Predictiva i Personalitzada del Càncer,  AABB, ISBT, dbRBC - Blood Group Antigen Gene Mutation Database

Comments